← Eichor
Condition: Type 2 Dm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Type 2 Dm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
Phase N/A · 1 location(s) · Consorci Sanitari de l'Alt Penedès i Garraf · NCT07285330Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Phase 4 · 2 location(s) · Nabiqasim Industries (Pvt) Ltd · NCT06862739The United Kingdom National Registry for Myotonic Dystrophy
Phase N/A · 1 location(s) · Newcastle University · NCT04003363Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Phase N/A · 3 location(s) · Forschungsinstitut der Diabetes Akademie Mergentheim · NCT07212075Technology-Enabled Collaborative Care for Diabetes and Mental Health
NA · 1 location(s) · McMaster University · NCT07181863Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
Phase 4 · 1 location(s) · Fazaia Ruth Pfau Medical College · NCT06706791Impact of P53 and SIRT1 in Type 2 Diabetes
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03925714Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM
NA · 1 location(s) · EVYD Technology · NCT06810986Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA · 7 location(s) · Duke University · NCT06906627Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Phase N/A · 1 location(s) · University of Rochester · NCT00082108MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT06031428Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
NA · 1 location(s) · Boston Medical Center · NCT07043426RCT Glargine vs NPH for Treatment of DM in Pregnancy
Phase 3 · 1 location(s) · Loyola University · NCT06619301NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06593327Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Phase 1/Phase 2 · 1 location(s) · David K Carroll · NCT07167693DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Phase 4 · 1 location(s) · Dong Wha Pharmaceutical Co. Ltd. · NCT06875193Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Phase N/A · 1 location(s) · Klavs Würgler Hansen · NCT07416656MiniMed Fit Payload Wear Pediatric Study
Phase N/A · 5 location(s) · Medtronic MiniMed, Inc. · NCT07675161Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes
NA · 1 location(s) · Medical College of Wisconsin · NCT06279637Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin
Phase 3 · 1 location(s) · Celltrion · NCT07093476A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Phase 1/Phase 2 · 26 location(s) · Vertex Pharmaceuticals Incorporated · NCT06185764Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy
Phase N/A · 1 location(s) · Sara A Belal · NCT07351786Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NA · 7 location(s) · Duke University · NCT06906640
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.